CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 61 filers reported holding CHEMOCENTRYX INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $1,356,000 | -85.3% | 101,261 | -43.8% | 0.00% | -85.7% |
| Q1 2021 | $9,236,000 | +28.7% | 180,255 | +55.5% | 0.01% | +16.7% |
| Q4 2020 | $7,177,000 | +15.8% | 115,911 | +2.5% | 0.01% | 0.0% |
| Q3 2020 | $6,199,000 | +8.6% | 113,122 | +14.0% | 0.01% | 0.0% |
| Q2 2020 | $5,709,000 | +56.7% | 99,218 | +9.4% | 0.01% | +50.0% |
| Q1 2020 | $3,644,000 | +24.3% | 90,685 | +22.4% | 0.00% | +33.3% |
| Q4 2019 | $2,931,000 | +836.4% | 74,100 | +60.6% | 0.00% | – |
| Q3 2019 | $313,000 | -10.1% | 46,126 | +23.4% | 0.00% | – |
| Q2 2019 | $348,000 | -62.9% | 37,391 | -44.6% | 0.00% | -100.0% |
| Q1 2019 | $937,000 | +27.3% | 67,452 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $736,000 | -13.7% | 67,452 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $853,000 | +3.1% | 67,452 | +7.4% | 0.00% | 0.0% |
| Q2 2018 | $827,000 | -3.2% | 62,800 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $854,000 | +128.3% | 62,800 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $374,000 | -19.7% | 62,800 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $466,000 | -20.7% | 62,800 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $588,000 | +28.7% | 62,800 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $457,000 | -1.7% | 62,800 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $465,000 | +22.7% | 62,800 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $379,000 | +34.4% | 62,800 | 0.0% | 0.00% | – |
| Q2 2016 | $282,000 | +80.8% | 62,800 | 0.0% | 0.00% | – |
| Q1 2016 | $156,000 | -69.4% | 62,800 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $509,000 | +33.9% | 62,800 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $380,000 | -26.5% | 62,800 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $517,000 | -6.8% | 62,800 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $555,000 | 0.0% | 62,800 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $555,000 | +96.1% | 62,800 | 0.0% | 0.00% | – |
| Q3 2014 | $283,000 | -22.9% | 62,800 | 0.0% | 0.00% | – |
| Q2 2014 | $367,000 | -1.1% | 62,800 | +6.4% | 0.00% | -100.0% |
| Q1 2014 | $371,000 | +6083.3% | 59,000 | +5800.0% | 0.00% | – |
| Q3 2013 | $6,000 | +50.0% | 1,000 | +233.3% | 0.00% | – |
| Q2 2013 | $4,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |